GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

[1]  M. V. van Zandvoort,et al.  Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cells , 2019, Cell Death & Disease.

[2]  Zaidi Mr.  The Interferon-Gamma Paradox in Cancer , 2019 .

[3]  M. Zaidi,et al.  The Interferon-Gamma Paradox in Cancer. , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[4]  Daniel E. Carlin,et al.  The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine. , 2018, Journal of molecular biology.

[5]  P. Agostinis,et al.  Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications , 2018, The FEBS journal.

[6]  V. Sreenivas,et al.  Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol , 2018, Systematic Reviews.

[7]  A. Popel,et al.  Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis , 2018, Breast cancer research : BCR.

[8]  M. Terry,et al.  Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? , 2018, Journal of global oncology.

[9]  S. Sleijfer,et al.  Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis , 2018, Journal of the National Cancer Institute.

[10]  R. Masetti,et al.  Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer. , 2018, European review for medical and pharmacological sciences.

[11]  O. Schilling,et al.  Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype , 2018, Scientific Reports.

[12]  Judith A. Smith.  Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity , 2018, Front. Immunol..

[13]  Aditi Banerjee,et al.  Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media , 2018, Glycobiology.

[14]  Amanda Haymond,et al.  Protein biomarkers for subtyping breast cancer and implications for future research , 2018, Expert review of proteomics.

[15]  T. Nielsen,et al.  Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. , 2017, Seminars in cancer biology.

[16]  J. Thaxton,et al.  Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function , 2017, Cancer Immunology Research.

[17]  Z. Horváth,et al.  Recent Advances in the Neoadjuvant Treatment of Breast Cancer , 2017, Journal of breast cancer.

[18]  J. H. Lee,et al.  Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis , 2017, International journal of molecular sciences.

[19]  E. Diamandis,et al.  Towards personalized tumor markers , 2017, npj Precision Oncology.

[20]  Chiara Riganti,et al.  PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy , 2017, Molecular Cancer.

[21]  Z. Dai,et al.  IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[22]  A. Ring,et al.  Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. , 2016, Breast.

[23]  S. Nierkens,et al.  Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses. , 2016, Critical reviews in oncology/hematology.

[24]  L. Zitvogel,et al.  Immunological Mechanisms Underneath the Efficacy of Cancer Therapy , 2016, Cancer Immunology Research.

[25]  Varsha Bhavnani,et al.  Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation. , 2016, The international journal of biochemistry & cell biology.

[26]  Randal J. Kaufman,et al.  The unfolded protein response in immunity and inflammation , 2016, Nature Reviews Immunology.

[27]  R. Yerushalmi,et al.  Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer , 2015, Oncology letters.

[28]  P. Khatri,et al.  Neoadjuvant chemotherapy in patients with locally advanced breast cancer: A pilot-observational study. , 2015, Journal of cancer research and therapeutics.

[29]  R. Talamini,et al.  Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy , 2015, Journal of Translational Medicine.

[30]  Changhua Wang,et al.  Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3 , 2015, PloS one.

[31]  C. Geyer,et al.  Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer , 2015, Annals of Surgical Oncology.

[32]  S. Loibl.  Neoadjuvant treatment of breast cancer: maximizing pathologic complete response rates to improve prognosis , 2015, Current opinion in obstetrics & gynecology.

[33]  R. Yerushalmi,et al.  Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells , 2014, Oncotarget.

[34]  V. Engelhard,et al.  Peripheral Tissue Homing Receptor Control of Naïve, Effector, and Memory CD8 T Cell Localization in Lymphoid and Non-Lymphoid Tissues , 2013, Front. Immunol..

[35]  Kuang-Yung Huang,et al.  Anti-citrullinated Protein Antibodies Activated ERK1/2 and JNK Mitogen-activated Protein Kinases via Binding to Surface-expressed Citrullinated GRP78 on Mononuclear Cells , 2013, Journal of Clinical Immunology.

[36]  K. Riesbeck,et al.  The Activation Pattern of Blood Leukocytes in Head and Neck Squamous Cell Carcinoma Is Correlated to Survival , 2012, PloS one.

[37]  Petra Macaskill,et al.  Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. , 2012, European journal of cancer.

[38]  N. Sharma,et al.  Indications for marker clip in the setting of neoadjuvant/neoendocrine therapy , 2012, Breast Cancer Research.

[39]  P. Vandenabeele,et al.  ER stress-induced inflammation: does it aid or impede disease progression? , 2012, Trends in molecular medicine.

[40]  Gun-Do Kim,et al.  Prospective impact of 5-FU in the induction of endoplasmic reticulum stress, modulation of GRP78 expression and autophagy in Sk-Hep1 cells. , 2012, International journal of oncology.

[41]  E. Diamandis,et al.  The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? , 2012, BMC Medicine.

[42]  H. Weiner,et al.  Overexpression of TGF-β1 Gene Induces Cell Surface Localized Glucose-Regulated Protein 78-Associated Latency-Associated Peptide/TGF-β , 2010, The Journal of Immunology.

[43]  A. Schönthal,et al.  Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. , 2009, Cancer letters.

[44]  Nizar M. Mhaidat,et al.  Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78 , 2009, Anti-cancer drugs.

[45]  P. van Endert,et al.  Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death , 2009, The EMBO journal.

[46]  Amy S. Lee,et al.  Stress induction of GRP78/BiP and its role in cancer. , 2006, Current molecular medicine.

[47]  Johan Hansson,et al.  Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling* , 2003, The Journal of Biological Chemistry.

[48]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[49]  Fiona J Gilbert,et al.  Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  W. Arap,et al.  GRP78 signaling hub a receptor for targeted tumor therapy. , 2010, Advances in genetics.

[51]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..